Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment

Enrolling by invitationOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

June 15, 2033

Study Completion Date

June 15, 2033

Conditions
Solid TumorsHematologic MalignancyGastrointestinal CancerLiver CancerPancreatic CancerMelanomaPre-MalignancyLung Cancer
Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH